One of the world's largest pharmaceutical companies apparently will not continue research and developmentof new drugs against Alzheimer's disease. This situation will leave millions of people in a vulnerable situation.Drugs approved for the treatment of the disease have not been viable and patients always return to thesymptoms of the disease. I am of the idea of a primarily pharmacological therapy, using already approvedmedications that could delay Alzheimer's disease or alleviate some of the symptoms of the disease. Thistherapy consists of rehabilitating the brain of the person with Alzheimer's, so that later, the drugs, such asacetylcholinesterase inhibitors and memantine act adequately in the neurons, making the treatment indicatedby neurologists more effective. This therapy is not expensive and could help the patient to lead a better qualityof life. I practically discussed the translational potential of various drugs that have been tested experimentally.
展开▼
